XML 73 R41.htm IDEA: XBRL DOCUMENT
v3.22.4

Schedule I (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Condensed Financial Statements, Captions [Line Items] |
Schedule of Maturities of Long-term Debt [Table Text Block] | Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:
(in millions) |  |
2023 |  | $ | 3,117 |
2024 |  | 3,136 |
2025 |  | 3,186 |
2026 |  | 2,636 |
2027 |  | 3,061 |
Thereafter |  | 43,638 |
Parent Company [Member] |
Condensed Financial Statements, Captions [Line Items] |
Condensed Balance Sheet [Table Text Block] | Condensed Financial Information of Registrant (Parent Company Only) UnitedHealth Group Condensed Balance Sheets
(in millions, except per share data) |  | December 31, 2022 |  | December 31, 2021
Assets |  |  |  |
Current assets: |  |  |  |
Cash and cash equivalents |  | $ | 266 |  |  | $ | 2,167 |
Other current assets |  | 753 |  |  | 503 |
Total current assets |  | 1,019 |  |  | 2,670 |
Equity in net assets of subsidiaries |  | 136,562 |  |  | 116,907 |
Long-term notes receivable from subsidiaries |  | 6,201 |  |  | 5,680 |
Other assets |  | 504 |  |  | 32 |
Total assets |  | $ | 144,286 |  |  | $ | 125,289 |
Liabilities and shareholders’ equity |  |  |  |
Current liabilities: |  |  |  |
Accounts payable and accrued liabilities |  | $ | 835 |  |  | $ | 605 |
Current portion of notes payable to subsidiaries |  | 8,699 |  |  | 8,105 |
Short-term borrowings and current maturities of long-term debt |  | 2,918 |  |  | 3,009 |
Total current liabilities |  | 12,452 |  |  | 11,719 |
Long-term debt, less current maturities |  | 53,838 |  |  | 41,623 |
Other liabilities |  | 224 |  |  | 187 |
Total liabilities |  | 66,514 |  |  | 53,529 |
Commitments and contingencies (Note 4) |  |  |  |
Shareholders’ equity: |  |  |  |
Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding |  | — |  |  | — |
Common stock, $0.01 par value - 3,000 shares authorized; 934 and 941 issued and outstanding |  | 9 |  |  | 10 |
Retained earnings |  | 86,156 |  |  | 77,134 |
Accumulated other comprehensive loss |  | (8,393) |  |  | (5,384) |
Total UnitedHealth Group shareholders’ equity |  | 77,772 |  |  | 71,760 |
Total liabilities and shareholders’ equity |  | $ | 144,286 |  |  | $ | 125,289 |
Condensed Statement of Comprehensive Income [Table Text Block] | Condensed Financial Information of Registrant (Parent Company Only) UnitedHealth Group Condensed Statements of Comprehensive Income
|  | For the Years Ended December 31,
(in millions) |  | 2022 |  | 2021 |  | 2020
Revenues: |  |  |  |  |  |
Investment and other income |  | $ | 255 |  |  | $ | 494 |  |  | $ | 194 |
Total revenues |  | 255 |  |  | 494 |  |  | 194 |
Operating costs: |  |  |  |  |  |
Operating costs |  | 121 |  |  | 40 |  |  | 27 |
Interest expense |  | 2,110 |  |  | 1,583 |  |  | 1,594 |
Total operating costs |  | 2,231 |  |  | 1,623 |  |  | 1,621 |
Loss before income taxes |  | (1,976) |  |  | (1,129) |  |  | (1,427) |
Benefit for income taxes |  | 429 |  |  | 231 |  |  | 300 |
Loss of parent company |  | (1,547) |  |  | (898) |  |  | (1,127) |
Equity in undistributed income of subsidiaries |  | 21,667 |  |  | 18,183 |  |  | 16,530 |
Net earnings |  | 20,120 |  |  | 17,285 |  |  | 15,403 |
Other comprehensive loss |  | (3,009) |  |  | (1,570) |  |  | (236) |
Comprehensive income |  | $ | 17,111 |  |  | $ | 15,715 |  |  | $ | 15,167 |
Condensed Cash Flow Statement [Table Text Block] | Condensed Financial Information of Registrant (Parent Company Only) UnitedHealth Group Condensed Statements of Cash Flows
|  | For the Years Ended December 31,
(in millions) |  | 2022 |  | 2021 |  | 2020
Operating activities |  |  |  |  |  |
Cash flows from operating activities |  | $ | 14,754 |  |  | $ | 11,439 |  |  | $ | 8,842 |
Investing activities |  |  |  |  |  |
Issuances of notes to subsidiaries |  | (567) |  |  | (444) |  |  | (628) |
Repayments of notes to subsidiaries |  | 281 |  |  | 37 |  |  | 1,089 |
Cash paid for acquisitions |  | (20,728) |  |  | (4,953) |  |  | (7,706) |
Return of capital to parent company |  | 1,424 |  |  | 245 |  |  | 943 |
Capital contributions to subsidiaries |  | (570) |  |  | (747) |  |  | (43) |
Cash received from dispositions |  | 2,787 |  |  | — |  |  | 143 |
Cash flows used for investing activities |  | (17,373) |  |  | (5,862) |  |  | (6,202) |
Financing activities |  |  |  |  |  |
Common stock repurchases |  | (7,000) |  |  | (5,000) |  |  | (4,250) |
Proceeds from common stock issuances |  | 1,253 |  |  | 1,355 |  |  | 1,440 |
Cash dividends paid |  | (5,991) |  |  | (5,280) |  |  | (4,584) |
Proceed from (repayments of) short-term borrowings, net |  | 732 |  |  | (1,302) |  |  | 872 |
Proceeds from issuance of long-term debt |  | 14,819 |  |  | 6,933 |  |  | 4,864 |
Repayments of long-term debt |  | (3,015) |  |  | (3,150) |  |  | (3,150) |
Proceeds from notes from subsidiaries |  | 594 |  |  | 3,223 |  |  | 2,818 |
Other, net |  | (674) |  |  | (447) |  |  | (438) |
Cash flows from (used for) financing activities |  | 718 |  |  | (3,668) |  |  | (2,428) |
(Decrease) increase in cash and cash equivalents |  | (1,901) |  |  | 1,909 |  |  | 212 |
Cash and cash equivalents, beginning of period |  | 2,167 |  |  | 258 |  |  | 46 |
Cash and cash equivalents, end of period |  | $ | 266 |  |  | $ | 2,167 |  |  | $ | 258 |
Supplemental cash flow disclosures |  |  |  |  |  |
Cash paid for interest |  | $ | 1,969 |  |  | $ | 1,575 |  |  | $ | 1,633 |
Cash paid for income taxes |  | 4,298 |  |  | 3,050 |  |  | 4,185 |
Schedule of Maturities of Long-term Debt [Table Text Block] | Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:
(in millions) |  |
2023 |  | $ | 2,925 |
2024 |  | 3,000 |
2025 |  | 3,050 |
2026 |  | 2,500 |
2027 |  | 2,925 |
Thereafter |  | 43,502 |

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | srt_CondensedFinancialStatementsCaptionsLineItems
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 12 -Paragraph (a) -Subsection 04 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690 + Details
Name: | srt_CondensedStatementOfComprehensiveIncomeTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 12 -Paragraph (a) -Subsection 04 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 12 -Paragraph (a) -Subsection 04 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690 + Details
Name: | srt_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of maturity and sinking fund requirement for long-term debt. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601 + Details
Name: | us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |